文献速递关节外科创伤骨科

氨甲环酸时代全髋关节置换术中的输血:谁需要在术前进行血型鉴定与筛查?

Blood Transfusion in the Age of Tranexamic Acid: Who Needs a Type and Screen Before Total Hip Arthroplasty?
PubMed 文献 · J Arthroplasty · 2024-06-22

该研究回顾了2014年1月至2023年1月单中心接受初次单侧全髋关节置换术并接受氨甲环酸的6405例患者,比较输血与未输血患者特征。结果显示术前血红蛋白>12 g/dL时围手术期输血率仅1.7%,而<11 g/dL时输血率达27.5%,作者认为可据此选择性进行血型鉴定与筛查。

要点

  • 术前血红蛋白>12 g/dL者围手术期输血率1.7%、术中输血率0.3%,输血罕见。
  • 术前血红蛋白11–12 g/dL者围手术期输血率14.3%、术中输血率4.6%。
  • 术前血红蛋白<11 g/dL者围手术期输血率27.5%、术中输血率10.1%,风险仍较高。

核心结论

  • 在氨甲环酸时代,术前血红蛋白>12 g/dL的全髋关节置换术患者输血罕见,对普遍进行血型鉴定与筛查的必要性提出挑战。
  • 术前血红蛋白<11.0 g/dL的患者仍面临较高的输血风险。
  • 血红蛋白11–12 g/dL时,患者年龄、性别、体质指数、美国麻醉医师学会分级、预计失血量和手术时间可能有助于预测输血风险及围手术期血型鉴定与筛查的需求。

研究设计与样本

  • 回顾性研究,纳入2014年1月至2023年1月期间在一家学术机构接受初次单侧全髋关节置换术、接受氨甲环酸且有术前血红蛋白值的6405例患者。
  • 比较输血与未输血患者的人口学特征、基线血红蛋白水平和手术细节,采用多因素回归和受试者工作特征曲线分析。

主要发现

  • 总体围手术期输血率为3.4%,术中输血率为1.0%。
  • 年龄较大、女性、美国麻醉医师学会分级>II级的患者输血风险增加。
  • 多因素分析显示,输血风险与术前血红蛋白水平呈负相关,与体质指数呈双峰关联,与年龄、手术时间和估计失血量呈正相关。
  • 受试者工作特征分析显示,预测任何输血的术前血红蛋白截断值为12 g/dL。
  • 血红蛋白>12 g/dL时,总体和术中输血率分别为1.7%和0.3%;血红蛋白11–12 g/dL时分别为14.3%和4.6%;血红蛋白<11 g/dL时分别为27.5%和10.1%。

关键数值与推荐

  • 术前血红蛋白截断值12 g/dL用于预测任何输血(受试者工作特征分析)。
  • 血红蛋白>12 g/dL:总体输血率1.7%,术中输血率0.3%。
  • 血红蛋白11–12 g/dL:总体输血率14.3%,术中输血率4.6%。
  • 血红蛋白<11 g/dL:总体输血率27.5%,术中输血率10.1%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Modern surgical protocols, particularly the use of tranexamic acid (TXA), have reduced, but not eliminated, blood transfusions surrounding total hip arthroplasty (THA). Identifying patients at risk for transfusion remains important for risk reduction and to determine type and screen testing. METHODS: We reviewed 6,405 patients who underwent primary, unilateral THA between January 2014 and January 2023 at a single academic institution, received TXA, and had preoperative hemoglobin (Hgb) values. We compared demographics, baseline Hgb levels, and surgical details between patients who were and were not transfused. Data were analyzed utilizing multivariate regression and receiver operating characteristic curve analysis. RESULTS: The overall perioperative and intraoperative transfusion rates were 3.4 and 1.0%, respectively. Patients who were older, women, and American Society of Anesthesiologists class >II demonstrated an increased risk of transfusion. Risk of transfusion demonstrated an inverse correlation with preoperative Hgb levels, a bimodal association with body mass index, and a direct correlation with age, surgical time, and estimated blood loss on multivariate analysis. The receiver operating characteristic analysis demonstrated a preoperative Hgb cutoff of 12 g/dL for predicting any transfusion. Above the threshold of 12 g/dL, total and intraoperative transfusions were rare, with rates of 1.7 and 0.3%, respectively. Total and intraoperative transfusion rates with Hgb between 11 and 12 g/dL were 14.3 and 4.6%, respectively. Below 11 g/dL, total and intraoperative transfusion rates were 27.5 and 10.1%, respectively. CONCLUSIONS: In the age of TXA, blood transfusion is rare in THA when preoperative Hgb is >12 g/dL, challenging the need for universal type and screening. Conversely, patients who have Hgb < 11.0 g/dL, remain at substantial risk for transfusion. Between Hgb 11 and 12 g/dL, patient age, sex, body mass index, American Society of Anesthesiologists classification, anticipated estimated blood loss, and surgical time may help predict transfusion risk and the need for a perioperative type and screen. LEVEL OF EVIDENCE: III.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Haider MA, Ward SA, Rajahraman V, et al. Blood Transfusion in the Age of Tranexamic Acid: Who Needs a Type and Screen Before Total Hip Arthroplasty? J Arthroplasty. 2024. PMID: 38914146. doi:10.1016/j.arth.2024.06.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。